Symptoms of Alpha-1 Antitrypsin Deficiency

The first signs in newborns. The earliest possible indicator of Alpha-1 is jaundice at birth, with elevated bilirubin and potential liver complications. This is why we advocate for testing every baby at birth. Early identification can prevent years of misdiagnosis and enable proactive monitoring.

The silent years. Many individuals with Alpha-1 experience no obvious symptoms for decades. Low circulating Alpha-1 Antitrypsin may still contribute to subtle health issues over time. Waiting for classic symptoms can mean lost years of potential intervention.

When classic symptoms do appear, they often include:

Respiratory issues

• Frequent shortness of breath
• Recurring colds, bronchitis, and lung infections
• Chronic cough in both smokers and non-smokers
• COPD and emphysema (often developing earlier than typical)
• Patterns sometimes described as hereditary emphysema when genetics are involved

Liver-related symptoms

• Jaundice (yellowing of eyes, skin, and mouth)
• Liver disease and swelling
• Abdominal swelling and distension
• Easy bruising

General health indicators

• Persistent fatigue and low energy
• Unexplained weight loss
• Allergies that persist year-round
• Frequent headaches

COPD and emphysema are among the largest search topics in lung health. AATD is an important genetic cause of emphysema and COPD, especially when disease appears early or in people with limited smoking history. If you or a clinician are asking "could this COPD be Alpha-1?", testing for AATD is worth discussing.

Learn more about care options on medications and treatments and AATD diagnosis and testing.

The Mark Egly Foundation is advancing a broader understanding of Alpha-1 symptoms based on research documented in Mark Egly's patent. Updates to medical standards of care that recognize a wider range of conditions remain a foundation goal. Broader condition links are labeled as research hypotheses on our disease catalog and hub pages.

Respiratory and ENT

• Asthma
• Persistent sniffling without nasal discharge
• Chronic earaches in infants and young children

Gastrointestinal

• Irritable bowel syndrome (IBS)
• Crohn's disease
• Other chronic digestive issues

Systemic conditions (research framing)

• Chronic pain syndromes
• Various forms of cancer (see AATD and cancer prevention)
• Many autoimmune diseases (see AATD and autoimmune diseases)
• Neurological conditions under study (see AATD and neurological conditions)

What are common AATD symptoms?

Shortness of breath, chronic cough, early emphysema or COPD, unexplained liver disease, and jaundice in newborns are among the most recognized signs. Many people have few obvious symptoms for years.

Can Alpha-1 cause COPD or emphysema?

Yes. Severe AATD is a known genetic contributor to emphysema and COPD. Not all COPD is caused by AATD, which is why testing matters in the right clinical context.

When should I ask about Alpha-1 testing?

Consider asking if you have early or unexplained lung disease, unexplained liver disease, a family history of AATD, or multiple chronic issues that do not fit a single explanation. Use our self-check as an education starting point only.

Is a symptom checker a diagnosis?

No. Our self-check does not diagnose AATD. Only clinical testing and your care team can confirm a diagnosis.

The traditional approach to Alpha-1 diagnosis often waits for obvious respiratory or liver symptoms. The Mark Egly Foundation advocates for:

• Universal newborn screening for Alpha-1 deficiency
• Broader symptom recognition in medical training and practice
• Earlier intervention to prevent disease progression
• Comprehensive research into the full spectrum of Alpha-1 effects

Consider Alpha-1 testing if you or a family member experiences:

• Unexplained respiratory issues, especially at a young age
• Liver disease without clear cause
• Family history of COPD, emphysema, or liver disease
• Multiple chronic conditions that seem unrelated
• Any combination of symptoms listed above

If you recognize these symptoms in yourself or a loved one, talk to your healthcare provider about Alpha-1 testing. A simple blood test can provide important answers.

The Mark Egly Foundation is here to support you through testing, diagnosis, and beyond. Explore newly diagnosed resources and ways to give if you want to support education and research.